Add-On ZIDA Sock Therapy for Overactive Bladder

Many people with overactive bladder (OAB) continue to experience symptoms despite pharmacologic treatment. This study evaluates the use of the ZIDA Control Sock, an FDA-cleared, noninvasive wearable device that delivers mild electrical stimulation near the ankle, as an adjunct to usual care. Adults with OAB-wet who remain symptomatic on stable medication will use the device at home once weekly for 12 weeks while continuing their prescribed therapy. The study collects clinical, patient-reported, and safety information during adjunctive device use.

NCT Number	NCT07432659
Lead Sponsor	Medical University of South Carolina Collaborators: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, Medtronic
Conditions	Overactive Bladder
Enrollment	20 participants
Start Date	2026-04-17
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-05-06